MICROVESSEL QUANTIFICATION AS A MEASURE OF ANGIOGENIC ACTIVITY IN BENIGN BREAST-TISSUE LESIONS - A MARKER FOR PRECANCEROUS DISEASE

  • Authors:
    • TA FREGENE
    • CM KELLOGG
    • KJ PIENTA
  • View Affiliations

  • Published online on: November 1, 1995     https://doi.org/10.3892/or.2.6.1181
  • Pages: 1181-1184
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Neovascularization is a key step in the transformation of normal breast tissue into a cancerous phenotype. We investigated the angiogenic activity of 58 cases of histologically confirmed benign breast lesions quantitating angiogenic activity by factor VIII highlighting of endothelial cells. The mean microvessel count (MVC) for all patients was 51 per 0.19 mm(2) in the area of highest angiogenic activity at x400 magnification (range 21-113 per mm(2)). MVC in benign tissues were similar to those found previously in cancer tissues. These data suggest that the 'angiogenic switch' occurs early in breast transformation and that a role may exist for the use of MVC in the identification of persons at heightened risk for subsequent development of breast cancer.

Related Articles

Journal Cover

November 1995
Volume 2 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
FREGENE T, KELLOGG C and PIENTA K: MICROVESSEL QUANTIFICATION AS A MEASURE OF ANGIOGENIC ACTIVITY IN BENIGN BREAST-TISSUE LESIONS - A MARKER FOR PRECANCEROUS DISEASE. Oncol Rep 2: 1181-1184, 1995
APA
FREGENE, T., KELLOGG, C., & PIENTA, K. (1995). MICROVESSEL QUANTIFICATION AS A MEASURE OF ANGIOGENIC ACTIVITY IN BENIGN BREAST-TISSUE LESIONS - A MARKER FOR PRECANCEROUS DISEASE. Oncology Reports, 2, 1181-1184. https://doi.org/10.3892/or.2.6.1181
MLA
FREGENE, T., KELLOGG, C., PIENTA, K."MICROVESSEL QUANTIFICATION AS A MEASURE OF ANGIOGENIC ACTIVITY IN BENIGN BREAST-TISSUE LESIONS - A MARKER FOR PRECANCEROUS DISEASE". Oncology Reports 2.6 (1995): 1181-1184.
Chicago
FREGENE, T., KELLOGG, C., PIENTA, K."MICROVESSEL QUANTIFICATION AS A MEASURE OF ANGIOGENIC ACTIVITY IN BENIGN BREAST-TISSUE LESIONS - A MARKER FOR PRECANCEROUS DISEASE". Oncology Reports 2, no. 6 (1995): 1181-1184. https://doi.org/10.3892/or.2.6.1181